Notably, regulating the differentiation of naïve CD4+ T cells into Th1, Th2, Th17, Th9, Th22, and Tregs is essential for eliminating immunosuppressive restrictions from the tumor environment and boosting effector T-cell activity [22, 23, 32]. This evidence concerns the gene CD4 and neoplasm.